The Discounted Cash Flow (DCF) valuation of Ironwood Pharmaceuticals Inc (IRWD) is 10.73 USD. With the latest stock price at 3.17 USD, the upside of Ironwood Pharmaceuticals Inc based on DCF is 238.4%.
Based on the latest price of 3.17 USD and our DCF valuation, Ironwood Pharmaceuticals Inc (IRWD) is a buy. buying IRWD stocks now will result in a potential gain of 238.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.4% | 7.0% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 7.79 - 16.03 | 10.73 |
| Upside | 145.7% - 405.7% | 238.4% |